CN1671726A - 3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药 - Google Patents

3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药 Download PDF

Info

Publication number
CN1671726A
CN1671726A CNA038177595A CN03817759A CN1671726A CN 1671726 A CN1671726 A CN 1671726A CN A038177595 A CNA038177595 A CN A038177595A CN 03817759 A CN03817759 A CN 03817759A CN 1671726 A CN1671726 A CN 1671726A
Authority
CN
China
Prior art keywords
compound
hours
solution
alkyl
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038177595A
Other languages
English (en)
Chinese (zh)
Inventor
T·C·亨宁格尔
M·J·马切拉格
B·A·马里内利
B·朱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CN1671726A publication Critical patent/CN1671726A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA038177595A 2002-05-31 2003-05-28 3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药 Pending CN1671726A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38448302P 2002-05-31 2002-05-31
US60/384,483 2002-05-31

Publications (1)

Publication Number Publication Date
CN1671726A true CN1671726A (zh) 2005-09-21

Family

ID=29712041

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038177595A Pending CN1671726A (zh) 2002-05-31 2003-05-28 3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药

Country Status (7)

Country Link
US (1) US6825172B2 (https=)
EP (1) EP1513856A1 (https=)
JP (1) JP2005531603A (https=)
CN (1) CN1671726A (https=)
AU (1) AU2003234650A1 (https=)
CA (1) CA2487918A1 (https=)
WO (1) WO2003102010A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104428308B (zh) * 2012-07-06 2016-11-09 合同酒精株式会社 环状大环内酯类化合物的分离方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100695322B1 (ko) 2005-02-23 2007-03-15 (주)에스.앤.디 메밀등겨로부터 수용성섬유소 및 파고피리톨의 저온 및 연속추출 방법
US20090075916A1 (en) * 2005-11-23 2009-03-19 Upadhyay Dilip J Use of Macrolide Derivatives for Treating Acne
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL114589A (en) 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
KR19990067492A (ko) * 1995-11-08 1999-08-25 스티븐 에프. 웨인스톡 트리사이클릭 에리트로마이신 유도체
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
DE69733723T2 (de) 1996-09-04 2006-04-20 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AU720921B2 (en) 1996-11-27 2000-06-15 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
US6037137A (en) * 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
WO1999021870A1 (en) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
US6169168B1 (en) 1997-10-29 2001-01-02 Taisho Pharmaceuticals Co., Ltd. Erythromycin A derivatives
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US6020521A (en) 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
ID30547A (id) 1999-04-16 2001-12-20 Kosan Biosciences Inc Zat anti-infeksi makrolida
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
GB9910079D0 (en) 1999-05-01 1999-06-30 Smithkline Beecham Plc Novel compounds
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
ATE250076T1 (de) 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
WO2001010880A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO2001010878A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1146051A3 (en) 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
NZ533282A (en) * 2001-12-05 2006-09-29 Ortho Mcneil Pharm Inc 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104428308B (zh) * 2012-07-06 2016-11-09 合同酒精株式会社 环状大环内酯类化合物的分离方法

Also Published As

Publication number Publication date
AU2003234650A1 (en) 2003-12-19
WO2003102010A1 (en) 2003-12-11
EP1513856A1 (en) 2005-03-16
CA2487918A1 (en) 2003-12-11
JP2005531603A (ja) 2005-10-20
US20040018994A1 (en) 2004-01-29
US6825172B2 (en) 2004-11-30

Similar Documents

Publication Publication Date Title
CN1241931C (zh) 大环内酯抗感染药物
CN100338061C (zh) 炔－芳基磷酸二酯酶－4抑制剂
CN1033974C (zh) 新的红霉素衍生物的制备方法
CN1098263C (zh) 吡啶－2－基－甲胺衍生物、其制备方法及其作为药物的用途
CN1257164C (zh) 芳香酰胺、其制备方法以及作为药物的应用
CN1129596C (zh) 头孢烯化合物的合成中间体
CN1414951A (zh) 药剂排出泵抑制药
CN1244202A (zh) 三环红霉素衍生物
CN1058779A (zh) 喹诺酮衍生物和含有该化合物的药物组合物
CN1585749A (zh) 类大麻苷受体配体
CN1240707C (zh) 2－卤代－6－0－取代的酮内酯衍生物
CN1066735C (zh) 头孢菌素类抗生素
CN1671856A (zh) 新的生理活性物质
CN1202116C (zh) 除虫菌素衍生物
CN1630661A (zh) 具有抗菌活性的大环内酯类化合物
CN1343215A (zh) 具有抗菌活性的6－o－取代大环内酯类化合物
CN1633444A (zh) 6－11双环酮大环内酯衍生物
CN1271363A (zh) 具有抗菌活性的3’－n－修饰的6－o－取代的红霉素酮基内酯衍生物
CN1299356A (zh) 喹喏酮羧酸衍生物及其盐
CN1585775A (zh) 可用作抗菌药的红霉素的6－o－酰基酮内酯衍生物
CN1269817C (zh) 脱卤代化合物
CN1249057C (zh) 用作抗菌剂的色烯基甲基嘧啶二胺
CN1589277A (zh) 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
CN1671726A (zh) 3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药
CN1043717A (zh) 头孢菌素化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned